1. |
Parratte S, Ollivier M, Argenson JN. Primary total knee arthroplasty for acute fracture around the knee. Orthop Traumatol Surg Res, 2018, 104(1S): S71-S80.
|
2. |
Stevenson I, McMillan TE, Baliga S, et al. Primary and secondary total knee arthroplasty for tibial plateau fractures. J Am Acad Orthop Surg, 2018, 26(11): 386-395.
|
3. |
王志猛, 路遥, 杨佳瑞, 等. 氨甲环酸结合术后引流管临时夹闭减少SchatzkerⅤ、Ⅵ型胫骨平台骨折围术期失血的效果. 中华创伤杂志, 2020, 36(1): 68-74.
|
4. |
Schnettler T, Papillon N, Rees H. Use of a tourniquet in total knee arthroplasty causes a paradoxical increase in total blood loss. J Bone Joint Surg (Am), 2017, 99(16): 1331-1336.
|
5. |
Wang Z, Lu Y, Wang Q, et al. Comparison of the effectiveness and safety of intravenous and topical regimens of tranexamic acid in complex tibial plateau fracture: a retrospective study. BMC Musculoskelet Disord, 2020, 21(1): 739.
|
6. |
Wang HY, Wang L, Luo ZY, et al. Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial. BMC Musculoskelet Disord, 2019, 20(1): 478.
|
7. |
Dao P, Massin P. Blood management in enhanced recovery after hip and knee replacement. Orthop Traumatol Surg Res, 2020, 106(1S): S1-S5.
|
8. |
Wang F, Nan L, Feng X, et al. The efficacy and safety of multiple-dose intravenous tranexamic acid in reducing perioperative blood loss in patients with thoracolumbar burst fracture. Clin Neurol Neurosurg, 2020, 193: 105766.
|
9. |
Wu XD, Tian M, He Y, et al. Efficacy of a three-day prolonged-course of multiple-dose versus a single-dose of tranexamic acid in total hip and knee arthroplasty. Ann Transl Med, 2020, 8(6): 307.
|
10. |
Zheng C, Ma J, Xu J, et al. The optimal regimen, efficacy and safety of tranexamic acid and aminocaproic acid to reduce bleeding for patients after total hip arthroplasty: A systematic review and Bayesian network meta-analysis. Thromb Res, 2023, 221: 120-129.
|
11. |
Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery, 1962, 51(2): 224-232.
|
12. |
Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology, 1983, 58(3): 277-280.
|
13. |
Spitler CA, Row ER, Gardner WE, et al. Tranexamic acid use in open reduction and internal fixation of fractures of the pelvis, acetabulum, and proximal femur: a randomized controlled trial. J Orthop Trauma, 2019, 33(8): 371-376.
|
14. |
Cai J, Ribkoff J, Olson S, et al. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. Eur J Haematol, 2020, 104(2): 79-87.
|
15. |
姚亮, 陈虹, 张世东, 等. SchatzkerⅤ、Ⅵ型胫骨平台骨折多轴锁定钢板内固定术前注射氨甲环酸对术后失血及血清炎性因子水平的影响. 临床外科杂志, 2022, 30(4): 328-330.
|
16. |
Thipparampall AK, Gurajala I, Gopinath R. The effect of different dose regimens of tranexamic acid in reducing blood loss during hip surgery. Indian J Anaesth, 2017, 61(3): 235-239.
|
17. |
Kane Z, Picetti R, Wilby A, et al. Physiologically based modelling of tranexamic acid pharmacokinetics following intravenous, intramuscular, sub-cutaneous and oral administration in healthy volunteers. Eur J Pharm Sci, 2021, 164: 105893.
|
18. |
Tzatzairis T, Drosos GI, Vogiatzaki T, et al. Multiple intravenous tranexamic acid doses in total knee arthroplasty without tourniquet: a randomized controlled study. Arch Orthop Trauma Surg, 2019, 139(6): 859-868.
|
19. |
Duque P, Mora L, Levy JH, et al. Pathophysiological response to trauma-induced coagulopathy: A comprehensive review. Anesth Analg, 2020, 130(3): 654-664.
|
20. |
Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee, 2000, 7(3): 151-155.
|
21. |
Guo WJ, Wang JQ, Zhang WJ, et al. Hidden blood loss and its risk factors after hip hemiarthroplasty for displaced femoral neck fractures: a cross-sectional study. Clin Interv Aging, 2018, 13: 1639-1645.
|
22. |
Lei Y, Huang Q, Huang Z, et al. Multiple-dose intravenous tranexamic acid further reduces hidden blood loss after total hip arthroplasty: A randomized controlled trial. J Arthroplasty, 2018, 33(9): 2940-2945.
|
23. |
崔丹荔, 雷一霆, 许宏, 等. 人工全髋关节置换术中首次大剂量联合术后五次静脉应用氨甲环酸的前瞻性临床研究. 中国修复重建外科杂志, 2019, 33(8): 935-939.
|
24. |
Moran J, Kahan JB, Morris J, et al. Tranexamic acid administration at hospital admission decreases transfusion rates in geriatric hip fracture patients undergoing surgery. Geriatr Orthop Surg Rehabil, 2022, 13: 21514593221124414.
|
25. |
马诗博, 孙雪飞, 李凌博, 等. 不同剂量氨甲环酸应用于颈后路椎板切除减压联合侧块螺钉内固定植骨融合术的安全性和有效性评估. 中国修复重建外科杂志, 2022, 36(12): 1506-1511.
|
26. |
Poeran J, Rasul R, Suzuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 2014, 349: g4829.
|
27. |
Zhang S, Huang Q, Xu B, et al. Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: A large, single-center, retrospective study. Medicine (Baltimore), 2018, 97(1): e9429.
|
28. |
Lighvani S, Baik N, Diggs JE, et al. Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT. Blood, 2011, 118(20): 5622-5630.
|
29. |
Andronicos NM, Chen EI, Baik N, et al. Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation. Blood, 2010, 115(7): 1319-1330.
|
30. |
Wasko MK, Bobecka-Wesołowska K, Tomasiuk R, et al. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin Chem Lab Med, 2015, 53(11): 1785-1792.
|
31. |
Grassin-Delyle S, Semeraro M, Lamy E, et al. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers. Br J Anaesth, 2022, 128(3): 465-472.
|
32. |
胡旭栋, 裴福兴, 沈彬, 等. 氨甲环酸减少全膝关节置换术失血量的有效性和安全性评价. 中国骨与关节外科, 2013, (z1): 52-56.
|
33. |
杨坤, 张颖佩, 李文靖, 等. 氨甲环酸口服与静脉应用在全膝髋关节置换围手术期有效性及安全性的Meta分析. 药物流行病学杂志, 2019, 28(10): 651-655.
|